Colgate-Palmolive Co <CL.N>: Raymond James raises target price to $102 from $100
CL•Related News
Pomdoctor targets recurring revenue growth with AI-enabled chronic disease membership subscriptions
POM•
Royalty Pharma names Greg Raskin SVP, head of academic initiatives
RPRX•
Venu Holding closes $25 million secured convertible debenture financing for Regent Bank Amphitheater project
VENU•
BorgWarner wins extension of high-voltage inverter programs with European OEM
BWA•
CMS finalizes new Medicare DRG reimbursement codes for Carlsmed aprevo lumbar fusion procedures
CARL•